BioDigit Database™

BioDigit Database includes clinical, sensor and digital data collected from different patient populations. The patients are generally followed for a long period of time with continuous data collection at home and frequent site visits.

This database is developed based on continuous research efforts that was started more than a decade ago in collaboration with leading research institutions and hospitals. This database effectively eliminates the need for early studies in many therapeutic areas and can be used for development and validation of digital biomarkers and endpoints.

BioSensics is actively working on expanding this database into new therapeutic areas and adding novel digital biomarkers to the studies. These efforts are supported in part by the National Institute of Health (NIH), and in part by pharmaceutical companies that partner with BioSensics in development and validation of digital biomarkers and endpoints. More recent studies include collection of imaging (e.g. brain MRI) and speech and handwriting data from the patients.

To get additional information about the BioDigit Database, please email info@biosensics.com.